Test 2

Please select your preferred language.

請選擇你慣用的語言。

请选择你惯用的语言。

English
中文简体
台灣繁體
香港繁體

登入

记住我

初到 Fridae?

Fridae Mobile

Advertisement
Highlights

More About Us

新闻&特写

« 较新的 | 较旧的 »
6 May 2002

cream for erectile dysfunction approved in HK

A cream for erectile dysfunction (ED) was approved for distribution in Hong Kong, the developer NexMed, Inc. announced on April 23.

A cream for erectile dysfunction (ED) was approved for distribution in Hong Kong, the developer NexMed, Inc. announced on April 23.

Viagra (Sildenafil citrate) is the oral medication available in the United States and elsewhere for treatment of ED. Impotence or ED is the failure to achieve or maintain your erection. Some men can initially get an erection but as they try to reach climax, their erection fades. Others find themselves unable to keep their erection during intercourse.

Manufactured by Pfizer Labs, Viagra helps you get and maintain an erection when you're sexually aroused. The cream now called Befar -- which uses the ingredient Alprox-TD -- offers an alternative to Viagra.

NexMed has been selling their product in China since July 2001. "During 2002, we anticipate additional approvals and filings in various international markets," said Dr. Y. Joseph Mo, president and chief executive officer of NexMed. In clinical studies conducted in China, Befar showed a faster onset time and had a minimal side effect profile, according to NexMed.

NexMed is conducting its Phase 3 clinical development programs for Alprox-TD in the United States. Up to 2,500 patients with mild to severe ED will participate in the trials. NexMed has also completed a Phase 2 study with its Femprox topical treatment for female sexual arousal disorder ("FSAD").

Hong Kong

读者回应

抢先发表第一个回应吧!

请先登入再使用此功能。

Social


请选择新闻及专栏版本

精选个人档案

Now ALL members can view unlimited profiles!

Languages

View this page in a different language:

赞好

合作伙伴

 ILGA Asia - Fridae partner for LGBT rights in Asia IGLHRC - Fridae Partner for LGBT rights in Asia

Advertisement